• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Gastroenterol . Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study

tetano

Editor, Senior Moderator
World J Gastroenterol


. 2021 Aug 28;27(32):5448-5459.
doi: 10.3748/wjg.v27.i32.5448.
Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study


Lorenzo Norsa[SUP] 1 [/SUP], Pietro Andrea Bonaffini[SUP] 2 [/SUP], Maja Caldato[SUP] 3 [/SUP], Cristiana Bonifacio[SUP] 4 [/SUP], Aurelio Sonzogni[SUP] 5 [/SUP], Amedeo Indriolo[SUP] 6 [/SUP], Clarissa Valle[SUP] 2 [/SUP], Federica Furfaro[SUP] 7 [/SUP], Alice Bonanomi[SUP] 8 [/SUP], Paolo Niccolò Franco[SUP] 8 [/SUP], Mauro Gori[SUP] 9 [/SUP], Veronica Smania[SUP] 10 [/SUP], Lucia Scaramella[SUP] 10 [/SUP], Laura Forzenigo[SUP] 11 [/SUP], Maurizio Vecchi[SUP] 10 [/SUP], Monica Solbiati[SUP] 12 [/SUP], Giorgio Costantino[SUP] 12 [/SUP], Silvio Danese[SUP] 7 [/SUP], Lorenzo D'Antiga[SUP] 13 [/SUP], Sandro Sironi[SUP] 2 [/SUP], Luca Elli[SUP] 10 [/SUP]



Affiliations

Abstract

Background: Intestinal ischemia has been described in case reports of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (coronavirus disease 19, COVID-19).
Aim: To define the clinical and histological, characteristics, as well as the outcome of ischemic gastrointestinal manifestations of SARS-CoV-2 infection.
Methods: A structured retrospective collection was promoted among three tertiary referral centres during the first wave of the pandemic in northern Italy. Clinical, radiological, endoscopic and histological data of patients hospitalized for COVID-19 between March 1[SUP]st[/SUP] and May 30[SUP]th[/SUP] were reviewed. The diagnosis was established by consecutive analysis of all abdominal computed tomography (CT) scans performed.
Results: Among 2929 patients, 21 (0.7%) showed gastrointestinal ischemic manifestations either as presenting symptom or during hospitalization. Abdominal CT showed bowel distention in 6 patients while signs of colitis/enteritis in 12. Three patients presented thrombosis of main abdominal veins. Endoscopy, when feasible, confirmed the diagnosis (6 patients). Surgical resection was necessary in 4/21 patients. Histological tissue examination showed distinctive features of endothelial inflammation in the small bowel and colon. Median hospital stay was 9 d with a mortality rate of 39%.
Conclusion: Gastrointestinal ischemia represents a rare manifestation of COVID-19. A high index of suspicion should lead to investigate this complication by CT scan, in the attempt to reduce its high mortality rate. Histology shows atypical feature of ischemia with important endotheliitis, probably linked to thrombotic microangiopathies.

Keywords: COVID-19; Coronavirus; Endothelial inflammation; Ischemic colitis; Small bowel ischemia.
 
Back
Top Bottom